Screener
Innoviva, Inc. INVA Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Innoviva, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:26 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335235
FAQ
- What is Innoviva, Inc.'s cash & equivalents?
- Innoviva, Inc. (INVA) reported cash & equivalents of $570.39M in Q2 2026.
- How has Innoviva, Inc.'s cash & equivalents changed year-over-year?
- Innoviva, Inc.'s cash & equivalents increased by 43.5% year-over-year, from $397.53M to $570.39M.
- What is the long-term trend for Innoviva, Inc.'s cash & equivalents?
- Over 5 years (2020 to 2025), Innoviva, Inc.'s cash & equivalents has grown at a 17.5% compound annual growth rate (CAGR), from $246.49M to $550.94M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about Innoviva, Inc.'s cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude